Stephane Peluso - Aug 2, 2022 Form 4 Insider Report for INFINITY PHARMACEUTICALS, INC. (INFI)

Signature
/s/ Stephane Peluso
Stock symbol
INFI
Transactions as of
Aug 2, 2022
Transactions value $
$9,932
Form type
4
Date filed
8/4/2022, 06:26 PM
Previous filing
Jan 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INFI Common Stock Options Exercise +50K +2443.79% 52K Aug 2, 2022 Direct F1
transaction INFI Common Stock Sale $9.93K +15K +67.98% $0.66* 37.1K Aug 2, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFI Restricted Stock Unit Options Exercise $0 -50K -100% $0.00* 0 Aug 2, 2022 Common Stock 50K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs") convert into Common Stock of the issuer on a one-for-one basis. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date.
F2 Represents the shares automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of the RSUs listed in Table II. This sale does not represent a discretionary trade by the reporting person.
F3 On August 2, 2021, the reporting person was granted RSUs, of which all 50,000 vested as of August 2, 2022.